Cetera Investment Advisers
GMAB icon

Cetera Investment Advisers’s Genmab GMAB Stock Holding History

Cetera Investment Advisers’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.18M Sell
81,420
-2,504
-3% -$75K ﹤0.01% 2211
2025
Q4 		$2.58M Buy
83,924
+9,929
+13% +$309K ﹤0.01% 1996
2025
Q3 		$2.27M Buy
+73,995
New +$1.8M ﹤0.01% 2063
2024
Q4 		– Sell
-11,508
Closed -$281K – 3822
2024
Q3 		$281K Buy
11,508
+2,685
+30% +$71.8K ﹤0.01% 3121
2024
Q2 		$222K Sell
8,823
-2,250
-20% -$63.8K ﹤0.01% 3294
2024
Q1 		$331K Buy
+11,073
New +$325K ﹤0.01% 2949
2023
Q4 		– Sell
-7,695
Closed -$271K – 2277
2023
Q3 		$271K Sell
7,695
-805
-9% -$30.7K ﹤0.01% 1796
2023
Q2 		$323K Sell
8,500
-2,314
-21% -$92.3K ﹤0.01% 1690
2023
Q1 		$408K Sell
10,814
-6,201
-36% -$238K ﹤0.01% 1536
2022
Q4 		$721K Buy
17,015
+4,482
+36% +$185K 0.01% 1161
2022
Q3 		$403K Buy
+12,533
New +$440K 0.01% 1093
2022
Q1 		– Sell
-7,462
Closed -$295K – 1928
2021
Q4 		$295K Buy
7,462
+620
+9% +$25.9K ﹤0.01% 1499
2021
Q3 		$299K Buy
6,842
+1,815
+36% +$81.5K ﹤0.01% 1443
2021
Q2 		$205K Buy
+5,027
New +$194K ﹤0.01% 1658

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Cetera Investment Advisers's GMAB Position: Q1 2026 in Review

Cetera Investment Advisers reduced its Genmab (GMAB) stake by 3% in Q1 2026, selling an estimated $75K and leaving 81,420 shares worth $2.18M. The position accounts for ﹤0.01% of the portfolio, ranked #2211.

Cetera Investment Advisers first reported a position in GMAB in Q2 2021 and has held it in 14 quarters since. The position peaked at $2.58M in Q4 2025. 272 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • Cetera Investment Advisers held 81,420 shares of Genmab worth $2.18M as of Q1 2026.
  • Cetera Investment Advisers sold 2,504 Genmab shares in Q1 2026, an estimated $75K.
  • Genmab made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q1 2026, its #2211 holding.
  • Cetera Investment Advisers first reported a position in Genmab in Q2 2021 and has held it in 14 quarters since.
  • Cetera Investment Advisers's Genmab position peaked at $2.58M in Q4 2025.
  • 272 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.